Personal Care Chemicals

DMDM Hydantoin in the Bedroom

DMDM hydantoin is a cosmetic preservative that doesn't quite get treated as itself. The chemistry of toxicological concern isn't the parent compound — it's the formaldehyde that DMDM hydantoin slowly releases inside the cosmetic formulation to produce its antimicrobial effect. The same speciation-matters distinction applies here as for Cr-VI vs Cr-III or inorganic vs organic arsenic in the Heavy Metals family: the chemical sold on the ingredient label and the chemical doing the biological work are different, and the regulatory framing has to account for that distinction.

DMDM hydantoin is the most common formaldehyde-releasing preservative in US cosmetics. The released formaldehyde — IARC Group 1 carcinogen, with extensive separately-documented health effects — is what the regulatory frameworks (EU Cosmetics Regulation, FDA, CIR Safety Assessment) actually evaluate, with the parent compound permitted at concentration levels chosen to keep released formaldehyde below thresholds that produce measurable health effects under most use scenarios. This page covers what the evidence shows about that exposure picture.

At a glance

Chemical familyFormaldehyde-releasing cosmetic preservative; in-product hydrolysis releases formaldehyde for antimicrobial effect. Other formaldehyde-releasers in the same class: quaternium-15, imidazolidinyl urea, diazolidinyl urea, sodium hydroxymethylglycinate, bronopol
CAS number6440-58-0; chemical name 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin (DMDMH)
ClassificationDMDM hydantoin itself: not formally evaluated by IARC. Released formaldehyde: IARC Group 1 (carcinogenic to humans, Monograph Vol 100F, 2012). EU Cosmetics Regulation 1223/2009 Annex V permits DMDM hydantoin at up to 0.6% in finished products; "contains formaldehyde" labeling required when finished product contains >0.05% free formaldehyde. CIR Safety Assessment supports current use levels. US FDA permits DMDM hydantoin in cosmetics under broader cosmetic regulation
Where you encounter itShampoos, conditioners, hair gels and styling products; liquid hand soaps; lotions, sunscreens; makeup remover; baby wipes; mascara; body washes. de Groot's 2010 cosmetic survey documented DMDM hydantoin as one of the most common formaldehyde-releasing preservatives in US and EU consumer products
Sleep micro environment relevanceIndirect but real — leave-on hair products (gels, leave-in conditioners) containing DMDM hydantoin transfer to pillowcases overnight with continuing formaldehyde release. Bathroom-air formaldehyde during morning and evening hair-product application produces brief inhalation exposure. The released-formaldehyde exposure pathway is the bedroom-relevant chemistry, not the parent compound
Activated carbon captureLimited applicability for product-residue dermal exposure; activated carbon can capture released formaldehyde from bathroom air during application, but the dominant residential exposure pathway is product application rather than ambient air. The primary intervention is product-choice level. Inferred from established formaldehyde-releaser exposure pathways

What it is

DMDM hydantoin — CAS 6440-58-0, full chemical name 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin — is a synthetic formaldehyde-releasing preservative used in cosmetic and personal care formulations since the 1970s. The molecule contains two hydroxymethyl (-CH₂OH) groups attached to the nitrogen atoms of a 5,5-dimethylhydantoin ring; these hydroxymethyl groups hydrolyze slowly in the aqueous environment of the cosmetic formulation to release formaldehyde, which is the actual antimicrobial agent providing the preservation effect. The release rate is slow enough that free formaldehyde in the product at any single point in time remains at sub-percent concentrations, but cumulative release over the product's shelf life is sufficient to maintain antimicrobial activity.

The formaldehyde-releaser preservative class includes multiple structurally distinct compounds with the same functional behavior: quaternium-15 (1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride) releases formaldehyde through a different chemical pathway and is the strongest contact allergen of the class; imidazolidinyl urea and diazolidinyl urea are related hydantoin and urea derivatives with intermediate sensitization profiles; sodium hydroxymethylglycinate and bronopol (2-bromo-2-nitropropane-1,3-diol) use yet other release chemistries. The class shares the released-formaldehyde exposure pathway; for individuals with documented formaldehyde sensitivity or formaldehyde-releaser contact dermatitis, the entire class needs to be avoided rather than just one compound.

The released formaldehyde itself is the IARC Group 1 carcinogen, with extensive separately-documented health effects covered on the formaldehyde atlas page. The clinical question for the cosmetic-use case is the absorbed dose: how much released formaldehyde reaches systemic circulation from typical leave-on and rinse-off product use, and how that compares to the inhalation exposures from building materials, smoke, and combustion sources that drive most regulatory formaldehyde concern.

Where you encounter it

From shampoos and conditioners

The largest single use category by product volume. Most major mass-market shampoo and conditioner brands have used DMDM hydantoin or a structurally similar formaldehyde-releaser at some point; the post-2010s consumer pressure toward "formaldehyde-free" formulations has driven substantial industry shifts, but the class remains widely used. Rinse-off products produce lower per-application formaldehyde exposure than leave-on products because most of the product is washed off within minutes — but the residual film on skin and scalp continues to release formaldehyde over the following hours.

From leave-on hair products

Leave-in conditioners, hair gels, hair sprays, and styling products produce the highest residence-time exposure within the formaldehyde-releaser class. The product remains in contact with hair and scalp for the rest of the day, with continuing formaldehyde release during that period. For evening application before bed, the post-application formaldehyde release continues into the sleep window with pillowcase transfer. de Groot, White, Flyvholm, Lensen and Coenraads 2010 in Contact Dermatitis documented the prevalence of formaldehyde-releasers including DMDM hydantoin across cosmetic product categories. Peer-reviewed

From lotions, sunscreens, and skin products

Body lotions, hand creams, sunscreens, and similar leave-on skin products contain DMDM hydantoin in many mainstream formulations. The all-over body application produces measurable cumulative dermal contact, and the per-product systemic absorption is small but documented. The cumulative effect across multiple daily leave-on products in a typical personal care routine is substantially larger than any single product's contribution.

From makeup and cosmetic products

Mascara, foundation, concealer, and similar cosmetic products use DMDM hydantoin in some formulations. The application areas include sensitive skin regions (periocular skin for mascara, face skin for foundation) with relatively high permeability. For users with formaldehyde sensitivity, cosmetic product ingredient labels deserve specific scrutiny.

From hand soaps and body washes

Liquid hand soaps, body washes, baby wipes, and similar rinse-off cleansing products commonly contain DMDM hydantoin or related releasers. The rinse-off nature reduces per-application exposure, but frequency of hand-soap use makes the cumulative dose meaningful for some consumers. Baby wipe DMDM hydantoin content has driven specific consumer concern around infant exposure.

What the research says

Contact dermatitis — the dominant clinical endpoint

The most common documented health endpoint for DMDM hydantoin and the broader formaldehyde-releaser class is allergic contact dermatitis. de Groot, Flyvholm, Lensen, Menné and Coenraads 2009 in Contact Dermatitis reviewed the relationship between formaldehyde-releasers and formaldehyde contact allergy, establishing that nearly all formaldehyde-allergic patients react to DMDM hydantoin in patch testing, and that DMDM hydantoin is a frequent positive test result in dermatology clinics. Peer-reviewed de Groot and Veenstra 2010 in the same journal documented the cosmetic-product distribution of formaldehyde-releasers across US and EU markets. Peer-reviewed For sensitized patients, avoiding the entire formaldehyde-releaser class is the standard clinical recommendation rather than avoiding only the specific compound that produced the original sensitization.

Released formaldehyde as the underlying chemical of concern

The IARC Monograph Volume 100F (2012) classified formaldehyde as Group 1 — carcinogenic to humans — based on nasopharyngeal cancer and leukemia evidence from occupationally exposed populations (anatomy workers, embalmers, industrial formaldehyde producers). Regulatory The Group 1 classification applies to the released formaldehyde from DMDM hydantoin and the broader formaldehyde-releaser class, not to the parent preservatives themselves. The exposure dose at typical cosmetic use is substantially below the occupational inhalation exposures that anchor the Group 1 classification; the consumer relevance is the cumulative low-dose exposure across many product uses over years.

CIR safety assessment — the industry-funded review

The Cosmetic Ingredient Review Safety Assessment of DMDM Hydantoin conducted the structured industry safety review and concluded the current use levels of DMDM hydantoin are safe for cosmetic preservation given the released-formaldehyde concentration profile. Industry investigation CIR is the formal industry review body; as with parabens, the assessment is best evaluated alongside the independent regulatory frameworks (EU SCCS, EU Cosmetics Regulation) rather than as a primary source.

EU regulatory framework — labeling concession reflects exposure reality

EU Cosmetics Regulation No. 1223/2009 Annex V permits DMDM hydantoin at up to 0.6% in finished cosmetic products, with a labeling requirement: when the finished product contains more than 0.05% free formaldehyde from any source (including formaldehyde-releasers), the product label must declare "contains formaldehyde." Regulatory The labeling concession is a regulatory acknowledgment that formaldehyde-releasing preservatives produce real formaldehyde exposure even when the parent compound is permitted, and that consumers — particularly formaldehyde-sensitive consumers — need disclosure to make informed choices. The US FDA has not implemented an equivalent labeling requirement.

Patch-test clinic prevalence data

North American Contact Dermatitis Group (NACDG) and International Contact Dermatitis Research Group (ICDRG) patch-test data consistently rank DMDM hydantoin, quaternium-15, and the broader formaldehyde-releaser class among the most common positive cosmetic-ingredient allergens. Peer-reviewed — established clinical patch-test prevalence The clinical relevance for the general population is small (most people don't develop contact allergy to formaldehyde-releasers), but for the formaldehyde-sensitized subpopulation the class is one of the most clinically relevant cosmetic exposures.

What helps reduce exposure

Check ingredient lists for formaldehyde-releasing preservatives. The specific compounds to look for: DMDM hydantoin, quaternium-15, imidazolidinyl urea, diazolidinyl urea, sodium hydroxymethylglycinate, bronopol (2-bromo-2-nitropropane-1,3-diol), and methenamine. For products that disclose preservation chemistry transparently, the choice is straightforward.

For known formaldehyde sensitivity: avoid the entire class. Patch-test-positive patients react across the formaldehyde-releaser family rather than only to the original sensitizing compound. Dermatology and allergy clinicians provide patient handouts listing the full class for patient guidance.

Ventilate the bathroom aggressively during and after leave-in hair product use. The highest single-event formaldehyde exposure from cosmetic formaldehyde-releasers is bathroom-air formaldehyde during application of leave-in hair gels, sprays, and similar concentrated products. Running the bathroom fan during and for at least 15-30 minutes after application substantially reduces the inhalation pathway.

For infants and young children: prioritize formaldehyde-releaser-free options for leave-on products specifically. The per-body-weight exposure for leave-on products is higher in young children than adults, and the cumulative exposure across many products in a typical child's routine can be substantial. Rinse-off products (shampoo, body wash) carry less per-application exposure than leave-on lotions and creams.

Read EU-labeled imported products for the "contains formaldehyde" disclosure. The EU labeling concession provides a meaningful informational shortcut: if an EU-labeled product carries the disclosure, you know the released formaldehyde exceeds 0.05%; if it doesn't carry the disclosure, the released formaldehyde is below that threshold even though the parent preservative may still be present.

What does NOT help

  • Buying "formaldehyde-free" products without checking the ingredient list. Some products labeled formaldehyde-free still contain formaldehyde-releasing preservatives that generate formaldehyde during product storage and use. The "free from" claim is technically true (the product doesn't contain added formaldehyde as such) while functionally misleading. Check the ingredient list for the formaldehyde-releaser names directly.
  • Assuming "natural" preservatives are formaldehyde-free. Some natural-derived preservatives are also releasers. The natural-vs-synthetic axis is not the relevant chemistry axis here.
  • Generic "non-toxic" or "clean beauty" labels. Unregulated marketing terms. Specific ingredient-list verification or third-party certification (EWG Verified, MADE SAFE) is the actionable verification level.
  • Switching to one alternative formaldehyde-releaser to avoid another. For formaldehyde-sensitive patients, the entire class needs avoidance. Switching from DMDM hydantoin to quaternium-15 or imidazolidinyl urea does not address the underlying released-formaldehyde concern.

Open research questions

  • Cumulative formaldehyde exposure from personal care vs other indoor sources — the building-materials and combustion formaldehyde literature is mature; the personal-care contribution to total daily formaldehyde dose has not been quantitatively integrated at population scale. Speculation re: integrated dose; established for individual pathways
  • Pediatric exposure assessment for leave-on products — infant and young child cumulative formaldehyde-releaser exposure across daily personal care routines has not been precisely characterized. Speculation
  • Replacement preservative safety profiles — as formaldehyde-releaser-free formulations proliferate, the cumulative population exposure to alternative preservation chemistries (parabens, phenoxyethanol, sodium benzoate, isothiazolinones) is shifting without parallel exposure-assessment work. Inferred from the regrettable-substitution pattern documented for bisphenols and PFAS; preservative-replacement-specific data is sparse
  • Bedroom-specific exposure via leave-on product transfer to pillowcases and bedding — the released-formaldehyde transfer pathway during sleep has not been characterized at the residential measurement level. Speculation

Citations

  1. Cosmetic Ingredient Review. Safety Assessment of DMDM Hydantoin and Methenamine. cir-safety.org Industry investigation — formal industry safety review
  2. de Groot AC, Flyvholm M-A, Lensen G, Menné T, Coenraads P-J (2009). Formaldehyde-releasers: relationship to formaldehyde contact allergy. Contact Dermatitis, 61(2):63-85. DOI 10.1111/j.1600-0536.2009.01582.x Peer-reviewed — foundational releasers/formaldehyde allergy review
  3. de Groot AC, White IR, Flyvholm M-A, Lensen G, Coenraads P-J (2010). Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy. Contact Dermatitis, 62(1):2-17. DOI 10.1111/j.1600-0536.2009.01615.x Peer-reviewed
  4. de Groot AC, Veenstra M (2010). Formaldehyde-releasers in cosmetics in the USA and in Europe. Contact Dermatitis, 62(4):221-224. DOI 10.1111/j.1600-0536.2009.01623.x Peer-reviewed
  5. European Commission. Cosmetics Regulation (EC) No. 1223/2009 — Annex V (list of preservatives), DMDM hydantoin entry; Article 19 labeling requirements including "contains formaldehyde" disclosure above 0.05% free formaldehyde. health.ec.europa.eu/cosmetic-products Regulatory
  6. International Agency for Research on Cancer (2012). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100F: Chemical Agents and Related Occupations — Formaldehyde Group 1 (carcinogenic to humans). Lyon: IARC. publications.iarc.who.int Regulatory — applies to released formaldehyde
  7. US Food and Drug Administration. Cosmetic Ingredient Names — labeling, ingredient declaration, and the framework permitting DMDM hydantoin in cosmetic formulations. fda.gov/cosmetics Regulatory
  8. Health Canada. Cosmetic Ingredient Hotlist — list of substances prohibited or restricted in cosmetics, including formaldehyde and formaldehyde-releaser provisions. canada.ca/health-canada Regulatory
  9. US Food and Drug Administration. Modernization of Cosmetics Regulation Act (MoCRA, 2022) — current US cosmetic regulatory framework as it affects formaldehyde-releaser oversight. fda.gov Regulatory
  10. Cosmetic Ingredient Review. Safety Assessment of Formaldehyde and Methylene Glycol as Used in Cosmetics — covers formaldehyde and formaldehyde-releasers collectively. cir-safety.org Industry investigation — formal industry safety review

Frequently asked questions

  • Does DMDM hydantoin contain formaldehyde?

    DMDM hydantoin itself is not formaldehyde — it is a formaldehyde-releasing preservative. Within a cosmetic formulation, DMDM hydantoin slowly hydrolyzes to release formaldehyde, which is what produces the antimicrobial preservation effect. The honest framing is that "DMDM hydantoin exposure" and "formaldehyde exposure" overlap: the released formaldehyde is the chemical of toxicological concern, and IARC's Group 1 carcinogen classification applies to the released form, not to DMDM hydantoin itself. The same speciation-matters distinction applies here as for Cr-VI vs Cr-III or inorganic vs organic arsenic in the Heavy Metals family.

  • Is DMDM hydantoin banned?

    Not banned. DMDM hydantoin remains permitted under EU Cosmetics Regulation No. 1223/2009 Annex V at concentrations up to 0.6% in finished products, with a labeling requirement that "contains formaldehyde" be added when the finished product produces more than 0.05% free formaldehyde. The US FDA permits DMDM hydantoin in cosmetics under the broader cosmetic regulation framework without specific concentration limits. The labeling concession reflects regulatory recognition that formaldehyde-releasing preservatives produce real formaldehyde exposure even when the parent compound is allowed.

  • What products contain DMDM hydantoin?

    Shampoos, conditioners, hair gels and styling products, liquid hand soaps, lotions, sunscreens, makeup remover, baby wipes, mascara, and body washes commonly contain DMDM hydantoin as a preservative. The de Groot 2010 cosmetic survey documented DMDM hydantoin as one of the most common formaldehyde-releasing preservatives in US and EU consumer products. Other formaldehyde-releasing preservatives in the same class with similar exposure profiles include quaternium-15, imidazolidinyl urea, diazolidinyl urea, sodium hydroxymethylglycinate, and bronopol — for individuals with formaldehyde sensitivity, avoiding the entire class is the appropriate approach rather than just one compound.

  • Is DMDM hydantoin safe for kids?

    For most children with no known formaldehyde sensitivity, occasional use within regulatory concentration limits is not the primary concern. The honest framing for parents: leave-on products applied to infant and young children's skin (lotions, sunscreens, leave-on hair products) produce relatively higher per-body-weight exposure than the same product on adults, and the cumulative exposure across many cosmetic products in a child's routine can be substantial. For infants and young children, prioritizing formaldehyde-releaser-free options for leave-on products specifically is reasonable. For children with diagnosed formaldehyde sensitivity or contact dermatitis, avoiding the entire formaldehyde-releaser class is required.

  • How is DMDM hydantoin different from regular formaldehyde exposure?

    The exposure pathway and concentration profile differ. Direct formaldehyde exposure typically happens via inhalation from building materials (engineered wood, certain insulation), tobacco smoke, or off-gassing of new furniture — relatively continuous low-level air exposure. DMDM hydantoin exposure happens via topical product application — periodic dermal and lower-level inhalation exposure during the application window. The released formaldehyde from DMDM hydantoin in a leave-on lotion produces measurable systemic absorption but less than industrial inhalation exposures. For the cosmetic use case, the inhalation pathway during application (formaldehyde off-gassing into bathroom air) is more relevant than dermal for systemic exposure assessment.

  • What's the difference between DMDM hydantoin and quaternium-15?

    Both are formaldehyde-releasing preservatives, structurally distinct but functionally similar. DMDM hydantoin (1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin) releases formaldehyde slowly through hydrolysis of the hydroxymethyl groups. Quaternium-15 (1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride) releases formaldehyde through a different chemical pathway but produces similar cosmetic preservation. Quaternium-15 is a stronger and more frequent contact allergen than DMDM hydantoin in patch-test clinic data; both are positive in formaldehyde-sensitive patients. EU regulation restricts quaternium-15 more tightly than DMDM hydantoin; both remain permitted at different concentration thresholds.

  • Why is DMDM hydantoin still used if it releases formaldehyde?

    Three reasons. First, the slow-release mechanism keeps free formaldehyde in the formulation at very low concentrations at any single point in time, sufficient for antimicrobial action but well below acute toxicity thresholds. Second, water-based cosmetic formulations require effective broad-spectrum preservation against bacterial and fungal contamination — alternatives with their own evidence bases exist but each carries its own concerns. Third, the regulatory frameworks (EU Cosmetics Regulation, US FDA cosmetic regulation) have determined that with appropriate concentration limits and labeling requirements, the preservation benefit outweighs the released-formaldehyde concern at typical use levels. Consumers with formaldehyde sensitivity should avoid the class entirely; others can make their own choice based on the labeling disclosure.

Related compounds


Embr Sleep is a sleep environment company researching the chemistry of the bedroom. See the methodology page for how this Atlas tags claims by evidence strength. For broader context on personal care chemistry and formaldehyde exposure pathways, see non-toxic bedroom and the formaldehyde atlas entry.

Last reviewed 2026-05-25. If you find a factual error, contact us.